December 2018 - Buhlmann Diagnostics Corp

Month: December 2018

Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring

IBDoc® Citation: Wei, S. , Tung, C. et al.  Experience of patients with inflammatory bowel disease in using a home fecal calprotectin test as an objective reported outcome for self-monitoring. Intestinal Research 2018;16(4):546-553. DOI: https://doi.org/10.5217/ir.2018.00052 PMID: 30301339 Highlights from this Publication “96% of the patients were satisfied with the home test..." “71% of patients preferred the home test method monitor
Continue Reading

Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis

IBDoc® Citation: Walsh,  A,  Kormilitzin, A et al. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis, Journal of Crohn's and Colitis, jjy184, PMID: 30445625   DOI: doi.org/10.1093/ecco-jcc/jjy184  Highlights from this Publication “This is the first prospective study to use validated endoscopic and histologic indices to determine the thresholds of
Continue Reading

IBDoc Canadian User Performance Evaluation

IBDoc® Citation: Alice C Moore, Vivian W Huang, Raymond Bourdages, Richard N Fedorak, Christian Reinhard, Yvette Leung, Brian Bressler, Greg Rosenfeld; IBDoc Canadian User Performance Evaluation, Inflammatory Bowel Diseases, , izy357, DOI: https://doi.org/10.1093/ibd/izy357 PMID: 30535387 Highlights from this Publication "The majority of patients found it easy-to-use and felt that most patients would be able to learn how to
Continue Reading

Clinical Trial Combines New Symptom App with IBDoc

Read a recent article from University of Otago on the success of a new smartphone app, IBDSmart, in synergy with BÜHLMANN IBDoc calprotectin home test. Highlight from this Article "The study showed there was no difference in terms of quality of life for patients whether they used the apps or had face-to-face meetings,”  Associate Professor
Continue Reading